Duane Roth Achievement Award
Duane Roth Achievement Award
  • Home
  • About The Award
  • About Duane
  • 2024 Recipient
  • Past Recipients
    • 2023 Recipient
    • 2022 Recipient
    • 2021 Recipient
    • 2020 Recipient
    • 2019 Recipient
    • 2018 Recipient
    • 2017 Recipient
    • 2016 Recipient
    • 2015 Recipient
    • 2014 Recipient
  • Press
  • Support
  • More
    • Home
    • About The Award
    • About Duane
    • 2024 Recipient
    • Past Recipients
      • 2023 Recipient
      • 2022 Recipient
      • 2021 Recipient
      • 2020 Recipient
      • 2019 Recipient
      • 2018 Recipient
      • 2017 Recipient
      • 2016 Recipient
      • 2015 Recipient
      • 2014 Recipient
    • Press
    • Support

  • Home
  • About The Award
  • About Duane
  • 2024 Recipient
  • Past Recipients
    • 2023 Recipient
    • 2022 Recipient
    • 2021 Recipient
    • 2020 Recipient
    • 2019 Recipient
    • 2018 Recipient
    • 2017 Recipient
    • 2016 Recipient
    • 2015 Recipient
    • 2014 Recipient
  • Press
  • Support

Sandra Horning, M.D. - 2017 Recipient

Executive Vice President, Global Development and Chief Medical Officer, Genentech 

Sandra Horning, M.D., Chief Medical Officer and Executive Vice President of Global Development for Genentech, was named the 2017 recipient of the Duane Roth Achievement Award. She is a champion of personalized therapies and she led the development and launch of multiple cancer therapies. 


Dr. Horning, a cancer survivor, has focused much of her work on developing new treatments for lymphoma, a cancer that affects the immune system, including leading clinical trials that eventually resulted in new, approved drug treatments for patients. In addition to bringing new treatments forward, she is a champion for the importance of an individual being mindful of his or her family and anticipating survivorship issues, such as fertility, secondary malignancies, cardiopulmonary and endocrine side-effects. 

Dr. Horning, a cancer survivor, has focused much of her work on developing new treatments for lymphoma, a cancer that affects the immune system, including leading clinical trials that eventually resulted in new, approved drug treatments for patients. 

Dr. Horning has had a distinguished career in cancer treatment and research, first as a practicing oncologist, investigator and professor at Stanford University for 25 years, then at the San Francisco-based biotech company, Genentech, where multiple cancer therapies were approved under her leadership. Dr. Horning also served as the American Society of Clinical Oncology (ASCO) president from 2005 to 2006. 

More about Dr. Horning

  • Genentech/Roche Retirement Announcement
  • Gilead Board of Directors Profile
  • Healthcare Businesswomen's Association Profile
  • LinkedIn
  • Stanford Medicine Faculty Profile

Copyright © 2014-2025 Duane Roth Achievement Award - All Rights Reserved.